Costco offers affordable prices for hairloss treatments like finasteride, dutasteride, and minoxidil. Users discuss prescription options and compare prices with services like Mark Cuban's Cost Plus Drugs and Amazon's RxPass.
A user is considering using RU58841 to treat hairloss and asks if it can be effective for 4-5 years. Some suggest starting with a lower concentration and debate the safety of RU58841 compared to approved drugs like finasteride.
The user's decision to shave their head rather than continue using drugs like finasteride and minoxidil to try and stop hairloss, as well as other suggestions such as scalp micropigmentation.
The conversation is about someone using minoxidil, finasteride, RU58841, and microneedling for hairloss treatment for nearly two years with ongoing improvement. They are questioning the likelihood of continued hair regrowth over a four-year period.
The conversation humorously discusses the unfairness of hairloss, highlighting various treatments like finasteride, minoxidil, red light therapy, and experimental drugs, while contrasting with people who have great hair despite unhealthy lifestyles. The original poster mentions experiencing side effects from switching to oral finasteride.
A Silicon Valley-backed company aims to cure hairloss. Exciting advancements include mRNA therapies, gene editing, hair cloning, AR degraders, anti-androgens, cell-based rejuvenation, and AI-based drug discovery, with hopes for FDA approval of GT20029 within 10 years.
Rice bran is claimed to be as effective as Minoxidil in promoting hair growth. The conversation discusses using rice bran as an alternative treatment for hairloss.
The conversation discusses using a combination of finasteride, spironolactone, minoxidil, retinol, azelaic acid, and caffeine for hairloss treatment. The user inquires about the limitations of these drugs and whether tretinoin would be more effective than retinol.
New hairloss treatments like GT20029, Clascoterone, and PP405 are being discussed, with concerns about how to apply multiple topicals alongside existing treatments like minoxidil and finasteride. Suggestions include creating a routine, mixing treatments, or minimizing redundancy in treatment stacks.
The conversation discusses hairloss treatments, specifically mentioning Minoxidil, finasteride, RU58841, and Xeljanz. The user inquires about Xeljanz and shares a link suggesting it may help with hairloss.
A new hairloss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.
PP405 is a new drug in Phase 2 trials for hairloss, generating cautious optimism among users. Some users are currently using finasteride and experiencing side effects, while others are skeptical about unapproved products being sold.
A 24-year-old male experienced hairloss and successfully treated it using a combination of Finasteride, Dutasteride, and Oral Minoxidil. He reported no side effects and plans to continue the treatment to maintain his hair.
Dutasteride users have mixed results in hairloss treatment, with some experiencing improvements and others worsening. Some report metabolic changes like weight gain or diabetes, while others have no significant side effects.
Treatments for hairloss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.
Finasteride and minoxidil are praised for effectively treating hairloss, with users sharing positive experiences and some discussing side effects. Others express concerns about limited treatment options and the need for more research and alternatives.
The user experienced significant hair regrowth after switching from finasteride and minoxidil to dutasteride. They believe dutasteride is highly effective for treating hairloss.
A 25-year-old is considering using saw palmetto for hairloss due to fear of finasteride side effects but is concerned about its effectiveness and cost compared to finasteride. They are seeking advice on whether saw palmetto has similar side effects to finasteride and if it's truly effective or just a placebo.
Concerns about the long-term safety of Minoxidil and Finasteride for hairloss, with suggestions to weigh risks and consider cost-effective options like cutting higher-dose pills. Some users prefer Minoxidil due to perceived safety.
Finasteride is discussed as a hairloss treatment with benefits like reduced prostate enlargement and skin aging, but it is not seen as a "fountain of youth." Users report mixed experiences, including side effects like decreased libido and dry eyes.
A drug that regrows body parts, but not hair, sparking debate on hairloss treatments. Discussions include the use of finasteride, dutasteride, and the potential for new methods to restore hair.
GT20029 is a topical treatment that degrades androgen receptors to prevent hair thinning and loss, potentially offering fewer side effects than systemic treatments like finasteride. Concerns include its impact on hair texture and potential systemic effects, with market availability speculated in 3 to 5 years.
The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hairloss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.
A 25-year-old is experiencing mild hairloss and is using a regimen including scalp brushing, dermarolling, topical minoxidil, caffeine, melatonin, and a DHT-blocking shampoo. Another person shares their struggle with hairloss due to drug use and plans to start finasteride while trying to quit drugs.
Some people claim Dutasteride worsened their hairloss, causing concern among users. Reasons suggested include initial shedding phases, incorrect attribution to Dutasteride when other factors are involved, genetic variations affecting drug response, and the possibility of non-authentic medication.
People are hopeful about future hairloss treatments like PP405, GT20029, and VDPHL01, while some are currently using finasteride and minoxidil. There is skepticism about the effectiveness of new treatments, and some advise against hair transplants until more promising drugs are available.
The conversation discusses GT20029, a new topical drug for hairloss and acne without notable side effects, which has been accepted for investigational use in China. Some users express skepticism about the legitimacy of the company and the potential for other drugs like RU58841 to be developed due to patent expiration and lack of profitability.